STOCK TITAN

Passage Bio, Inc. (PASG) Net Income by Year

PASG

Passage Bio, Inc. reported a net loss of $45.5M in fiscal year 2025. This represents an increase of 29.7% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Passage Bio, Inc. has filed alongside them.

FY2025 annual
Net Income -$45.5M
YoY +29.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PASG Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-4/AFY24S-4/AFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$45.5M+29.7%-$64.8M+36.5%-$102.1M+25.0%-$136.1M+26.6%-$185.4M-65.2%-$112.2M-145.9%-$45.6M

PASG Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'26S-4/AQ1'26S-4Q4'25S-4/AQ3'2510-QQ2'25S-4/AQ1'25S-4Q4'24S-4/AQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$7.8M+16.7%-$7.6M+50.9%N/A-$7.7M+59.9%-$9.4M+41.3%-$15.4M+7.8%N/A-$19.3M+28.7%-$16.0M+33.0%-$16.7M+51.3%N/A-$27.1M-1.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Passage Bio, Inc. financials

Frequently Asked Questions

What was Passage Bio, Inc.'s net income in fiscal year 2025?

Passage Bio, Inc. reported a net loss of $45.5M in fiscal year 2025.

How fast is Passage Bio, Inc.'s net income growing?

Passage Bio, Inc. (PASG) net income rose by 29.7% year over year, from -$64.8M to -$45.5M in fiscal year 2025.

How has Passage Bio, Inc.'s net income changed over the years?

Across the 7 fiscal years this page covers, Passage Bio, Inc. (PASG) net income went from -$45.6M in fiscal year 2019 to -$45.5M in fiscal year 2025.

Passage Bio, Inc. (PASG) reported -$7.8M in net income in Q2 2026. This represents an increase of 16.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Passage Bio, Inc. (PASG) reported on that line in every period on record.